Phase 2 clinical study of firicabtagene autoleucel (firi-cel); Interim analysis results expected to be reported in 1H’25 - - IND application for CRG-023, CARGO’s tri-specific CAR T, cleared by the FDA ...
US-based DXC has expanded its partnership with Ferrari to develop the next generation of advanced in-vehicle infotainment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback